IP Library › Granted Patent US 12,685,819
Granted Patent B2
US 12,685,819 · App. 18/327,752 · Granted Jul 21, 2026

Infusion devices and related meal bolus adjustment methods

Inventors: Louis J. Lintereur (Boise, ID); Anirban Roy (Agoura Hills, CA); Benyamin Grosman (Winnetka, CA); Patrick E. Weydt (Moorpark, CA); Neha J. Parikh (West Hills, CA); Di Wu (Palo Alto, CA); Ali Dianaty (Porter Ranch, CA)
Assignee: MEDTRONIC MINIMED, INC.
A61M5/1723A61B5/14532A61B5/4839A61B5/4866A61B5/7275G16H20/17G16H50/20A61M2205/3303A61M2205/52A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,685,819
App. No.
18/327,752
Filed
Jun 1, 2023
Granted
Jul 21, 2026
Kind
B2
Art Unit
3783
USPC
604/504
Abstract

Techniques disclosed herein relate to infusion devices and related meal bolus adjustment methods. In some embodiments, the techniques may involve determining an initial bolus amount. The techniques may further involve predicting a value for a first physiological condition based at least in part on the initial bolus amount. The techniques may further involve when the predicted value for the first physiological condition violates a threshold: identifying an adjusted bolus amount that results in the predicted value for the first physiological condition satisfying the threshold, and causing delivery of the adjusted bolus amount.

Claims (45)

1 . A processor-implemented method comprising:

determining an initial bolus amount;

predicting a value for a first physiological condition based at least in part on the initial bolus amount; and

when the predicted value for the first physiological condition violates a threshold:

identifying an adjusted bolus amount that results in the predicted value for the first physiological condition satisfying the threshold, and

causing delivery of the adjusted bolus amount.

2 . The method of claim 1 , further comprising:

obtaining an event indication,

wherein determining the initial bolus amount comprises determining the initial bolus amount based at least in part on the event indication.

3 . The method of claim 2 , wherein the event indication is a meal event indication.

4 . The method of claim 2 , wherein the event indication is an exercise event indication.

5 . The method of claim 2 , wherein the event indication is an acute stress event indication.

6 . The method of claim 1 , wherein identifying the adjusted bolus amount comprises searching a search space that is defined in part by the initial bolus amount.

7 . The method of claim 1 , wherein identifying the adjusted bolus amount comprises maximizing the adjusted bolus amount within a search space, wherein the adjusted bolus amount is less than the initial bolus amount.

8 . The method of claim 1 , wherein identifying the adjusted bolus amount comprises progressively reducing a search space to arrive at the adjusted bolus amount.

9 . The method of claim 1 , wherein identifying the adjusted bolus amount comprises progressively reducing a search space to maximize the adjusted bolus amount within the search space using one or more intermediate adjusted bolus amounts until reaching a termination condition, wherein progressively reducing the search space comprises, for each of the one or more intermediate adjusted bolus amounts within the search space:

determining a respective initial value for a second physiological condition at a time corresponding to an event indication based at least in part on the respective intermediate adjusted bolus amount;

predicting a respective value for the first physiological condition based at least in part on a carbohydrate amount corresponding to a meal at the time corresponding to the event indication and the respective initial value for the second physiological condition; and

identifying a subsequent intermediate bolus amount of the one or more intermediate adjusted bolus amounts between the respective intermediate adjusted bolus amount and a preceding bolus amount based at least in part on a relationship between the respective value for the first physiological condition and the threshold.

10 . The method of claim 9 , wherein the second physiological condition comprises a plasma insulin concentration.

11 . The method of claim 1 , wherein identifying the adjusted bolus amount comprises searching a search space using a golden ratio search for a maximum bolus dosage that maintains the predicted value for the first physiological condition satisfying the threshold.

12 . The method of claim 1 , wherein predicting the value for the first physiological condition is based at least in part on the initial bolus amount and an additional amount of fluid.

13 . The method of claim 12 , wherein the additional amount of fluid is determined based at least in part on identifying a fixed rate of automated delivery of the fluid implemented by an autonomous operating mode of a fluid infusion device.

14 . The method of claim 12 , wherein the additional amount of fluid is determined based at least in part on estimating a variable rate of automated delivery of the fluid implemented by an autonomous operating mode of a fluid infusion device.

15 . The method of claim 14 , wherein estimating the variable rate comprises simulating operation of a closed-loop control system.

16 . The method of claim 12 , further comprising:

obtaining historical fluid delivery data; and

determining an initial value for a second physiological condition at a time corresponding to an event indication based at least in part on the historical fluid delivery data,

wherein predicting the value for the first physiological condition is based at least in part on the additional amount of fluid and the initial value for the second physiological condition.

17 . The method of claim 12 , wherein the fluid comprises insulin.

18 . The method of claim 1 , wherein the first physiological condition comprises a glucose level.

19 . A system comprising:

one or more processors; and

one or more processor-readable storage media storing instructions which, when executed by the one or more processors, cause performance of:

determining an initial bolus amount;

predicting a value for a first physiological condition based at least in part on the initial bolus amount; and

when the predicted value for the first physiological condition violates a threshold:

identifying an adjusted bolus amount that results in the predicted value for the first physiological condition satisfying the threshold, and

causing delivery of the adjusted bolus amount.

20 . One or more non-transitory processor-readable media storing instructions which, when executed by one or more processors, cause performance of:

determining an initial bolus amount;

predicting a value for a first physiological condition based at least in part on the initial bolus amount; and

when the predicted value for the first physiological condition violates a threshold:

identifying an adjusted bolus amount that results in the predicted value for the first physiological condition satisfying the threshold, and

causing delivery of the adjusted bolus amount.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2023
From: LINTEREUR, LOUIS J.; ROY, ANIRBAN; GROSMAN, BENYAMIN; WEYDT, PATRICK E.; PARIKH, NEHA J.; WU, DI; DIANATY, ALI
To: MEDTRONIC MINIMED, INC.
Reel/Frame 063845/0508 →
Continuity (4)
Continuation 17231583 · Apr 15, 2021
Continuation 16275289 · Feb 13, 2019
Provisional Application 62739017 · Sep 28, 2018
Related Publication 20230302221A1 · Sep 28, 2023
References Cited (126)
US 4562751A · Nason et al. · 1986 [cited by applicant]
US 4685903A · Cable et al. · 1987 [cited by applicant]
US 4755173A · Konopka et al. · 1988 [cited by applicant]
US 5080653A · Voss et al. · 1992 [cited by applicant]
US 5097122A · Colman et al. · 1992 [cited by applicant]
US 5391250A · Cheney, II et al. · 1995 [cited by applicant]
US 5485408A · Blomquist · 1996 [cited by applicant]
US 5505709A · Funderburk et al. · 1996 [cited by applicant]
US 5522803A · Teissen-Simony · 1996 [cited by applicant]
US 5665065A · Colman et al. · 1997 [cited by applicant]
US 5800420A · Gross et al. · 1998 [cited by applicant]
US 5807375A · Gross et al. · 1998 [cited by applicant]
US 5925021A · Castellano et al. · 1999 [cited by applicant]
US 5954643A · Vanantwerp et al. · 1999 [cited by applicant]
US 6017328A · Fischell et al. · 2000 [cited by applicant]
US 6088608A · Schulman et al. · 2000 [cited by applicant]
US 6119028A · Schulman et al. · 2000 [cited by applicant]
US 6186982B1 · Gross et al. · 2001 [cited by applicant]
US 6246992B1 · Brown · 2001 [cited by applicant]
US 6248067B1 · Causey, III et al. · 2001 [cited by applicant]
US 6248093B1 · Moberg · 2001 [cited by applicant]
US 6355021B1 · Nielsen et al. · 2002 [cited by applicant]
US 6379301B1 · Worthington et al. · 2002 [cited by applicant]
US 6485465B2 · Moberg et al. · 2002 [cited by applicant]
US 6544212B2 · Galley et al. · 2003 [cited by applicant]
US 6554798B1 · Mann et al. · 2003 [cited by applicant]
US 6558320B1 · Causey, III et al. · 2003 [cited by applicant]
US 6558351B1 · Steil et al. · 2003 [cited by applicant]
US 6589229B1 · Connelly et al. · 2003 [cited by applicant]
US 6591876B2 · Safabash · 2003 [cited by applicant]
US 6641533B2 · Causey, III et al. · 2003 [cited by applicant]
US 6659980B2 · Moberg et al. · 2003 [cited by applicant]
US 6736797B1 · Larsen et al. · 2004 [cited by applicant]
US 6740072B2 · Starkweather et al. · 2004 [cited by applicant]
US 6749587B2 · Flaherty · 2004 [cited by applicant]
US 6752787B1 · Causey, III et al. · 2004 [cited by applicant]
US 6766183B2 · Walsh et al. · 2004 [cited by applicant]
US 6801420B2 · Talbot et al. · 2004 [cited by applicant]
US 6804544B2 · Van Antwerp et al. · 2004 [cited by applicant]
US 6817990B2 · Yap et al. · 2004 [cited by applicant]
US 6827702B2 · Lebel et al. · 2004 [cited by applicant]
US 6932584B2 · Gray et al. · 2005 [cited by applicant]
US 7003336B2 · Holker et al. · 2006 [cited by applicant]
US 7029444B2 · Shin et al. · 2006 [cited by applicant]
US 7066909B1 · Peter et al. · 2006 [cited by applicant]
US 7137964B2 · Flaherty · 2006 [cited by applicant]
US 7303549B2 · Flaherty et al. · 2007 [cited by applicant]
US 7323142B2 · Pendo et al. · 2008 [cited by applicant]
US 7399277B2 · Saidara et al. · 2008 [cited by applicant]
US 7402153B2 · Steil et al. · 2008 [cited by applicant]
US 7442186B2 · Blomquist · 2008 [cited by applicant]
US 7602310B2 · Mann et al. · 2009 [cited by applicant]
US 7621893B2 · Moberg et al. · 2009 [cited by applicant]
US 7647237B2 · Malave et al. · 2010 [cited by applicant]
US 7699807B2 · Faust et al. · 2010 [cited by applicant]
US 7727148B2 · Talbot et al. · 2010 [cited by applicant]
US 7785313B2 · Mastrototaro · 2010 [cited by applicant]
US 7806886B2 · Kanderian, Jr. et al. · 2010 [cited by applicant]
US 7819843B2 · Mann et al. · 2010 [cited by applicant]
US 7828764B2 · Moberg et al. · 2010 [cited by applicant]
US 7879010B2 · Hunn et al. · 2011 [cited by applicant]
US 7890295B2 · Shin et al. · 2011 [cited by applicant]
US 7892206B2 · Moberg et al. · 2011 [cited by applicant]
US 7892748B2 · Norrild et al. · 2011 [cited by applicant]
US 7901394B2 · Ireland et al. · 2011 [cited by applicant]
US 7942844B2 · Moberg et al. · 2011 [cited by applicant]
US 7946985B2 · Mastrototaro et al. · 2011 [cited by applicant]
US 7955305B2 · Moberg et al. · 2011 [cited by applicant]
US 7963954B2 · Kavazov · 2011 [cited by applicant]
US 7977112B2 · Burke et al. · 2011 [cited by applicant]
US 7979259B2 · Brown · 2011 [cited by applicant]
US 7985330B2 · Wang et al. · 2011 [cited by applicant]
US 8024201B2 · Brown · 2011 [cited by applicant]
US 8100852B2 · Moberg et al. · 2012 [cited by applicant]
US 8114268B2 · Wang et al. · 2012 [cited by applicant]
US 8114269B2 · Cooper et al. · 2012 [cited by applicant]
US 8137314B2 · Mounce et al. · 2012 [cited by applicant]
US 8181849B2 · Bazargan et al. · 2012 [cited by applicant]
US 8182462B2 · Istoc et al. · 2012 [cited by applicant]
US 8192395B2 · Estes et al. · 2012 [cited by applicant]
US 8195265B2 · Goode, Jr. et al. · 2012 [cited by applicant]
US 8202250B2 · Stutz, Jr. · 2012 [cited by applicant]
US 8207859B2 · Enegren et al. · 2012 [cited by applicant]
US 8226615B2 · Bikovsky · 2012 [cited by applicant]
US 8257259B2 · Brauker et al. · 2012 [cited by applicant]
US 8267921B2 · Yodfat et al. · 2012 [cited by applicant]
US 8275437B2 · Brauker et al. · 2012 [cited by applicant]
US 8277415B2 · Mounce et al. · 2012 [cited by applicant]
US 8292849B2 · Bobroff et al. · 2012 [cited by applicant]
US 8298172B2 · Nielsen et al. · 2012 [cited by applicant]
US 8303572B2 · Adair et al. · 2012 [cited by applicant]
US 8305580B2 · Aasmul · 2012 [cited by applicant]
US 8308679B2 · Hanson et al. · 2012 [cited by applicant]
US 8313433B2 · Cohen et al. · 2012 [cited by applicant]
US 8318443B2 · Norrild et al. · 2012 [cited by applicant]
US 8323250B2 · Chong et al. · 2012 [cited by applicant]
US 8343092B2 · Rush et al. · 2013 [cited by applicant]
US 8352011B2 · Van Antwerp et al. · 2013 [cited by applicant]
US 8353829B2 · Say et al. · 2013 [cited by applicant]
US 8474332B2 · Bente, IV et al. · 2013 [cited by applicant]
US 8548544B2 · Kircher, Jr. et al. · 2013 [cited by applicant]
US 8674288B2 · Hanson et al. · 2014 [cited by applicant]
US 10980942B2 · Lintereur et al. · 2021 [cited by applicant]
US 11712520B2 · Lintereur et al. · 2023 [cited by applicant]
US 20040193025A1 · Steil et al. · 2004 [cited by applicant]
US 20070123819A1 · Mernoe et al. · 2007 [cited by applicant]
US 20100160861A1 · Causey, III et al. · 2010 [cited by applicant]
US 20140066889A1 · Grosman et al. · 2014 [cited by applicant]
US 20150165117A1 · Palerm et al. · 2015 [cited by applicant]
US 20160174911A1 · Palerm et al. · 2016 [cited by applicant]
US 20160279336A1 · Roy · 2016 [cited by applicant]
US 20200101221A1 · Lintereur et al. · 2020 [cited by applicant]
US 20210228805A1 · Lintereur et al. · 2021 [cited by applicant]
JP 2005176280A · 2005 [cited by applicant]
JP 2005200730A · 2005 [cited by applicant]
JP 2014174393A · 2014 [cited by applicant]
WO 2020068191A1 · 2020 [cited by applicant]
Prosecution History from U.S. Appl. No. 16/275,289, dated Sep. 4, 2020 through Dec. 22, 2020, pp. 16. [cited by applicant]
EP Office Action dated Sep. 29, 2025 in EP Application No. 19733289.3. [cited by applicant]
International Preliminary Report on Patentability dated Apr. 8, 2021 in Application No. PCT/US2019/035636. [cited by applicant]
International Search Report and Written Opinion dated Aug. 22, 2019 in PCT Application No. PCT/US2019/035636. [cited by applicant]
JP Office Action dated Jun. 13, 2023, in application No. JP20210516812 with English translation. [cited by applicant]
U.S. Notice of Allowance dated Dec. 22, 2020, in U.S. Appl. No. 16/275,289. [cited by applicant]
U.S. Notice of Allowance dated Mar. 13, 2023, in U.S. Appl. No. 17/231,583. [cited by applicant]
U.S. Restriction requirement dated Sep. 4, 2020 in U.S. Appl. No. 16/275,289. [cited by applicant]
CA Office Action dated Mar. 16, 2026 in CA Application No. 3,110,085. [cited by applicant]